SUN Pharmaceutical Industries Limited — Melphalan Exporter Profile
Indian Pharmaceutical Exporter · #2 for Melphalan · $1.0M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #2 Indian exporter of Melphalan with $1.0M in export value and 22 verified shipments. SUN Pharmaceutical Industries Limited holds a 8.0% market share in Melphalan exports across 2 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Melphalan Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Melphalan?
SUN Pharmaceutical Industries Limited exports Melphalan to 2 countries. The largest destination is BELGIUM accounting for 79.6% of SUN Pharmaceutical Industries Limited's Melphalan shipments. These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Melphalan from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $379.7K | 12 |
| YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | BELGIUM | $204.6K | 7 |
| TARO PHARMACEUTICALS INC. | CANADA | $100.0K | 2 |
| TARO PHARMACEUTICALS INC., | CANADA | $50.0K | 1 |
SUN Pharmaceutical Industries Limited supplies Melphalan to 4 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM) and TARO PHARMACEUTICALS INC. (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Melphalan Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $11.1M worth of Melphalan through 838 shipments from 153 suppliers to 97 countries, serving 272 buyers globally. SUN Pharmaceutical Industries Limited contributes $1.0M to this total, accounting for 8.0% of India's Melphalan exports. SUN Pharmaceutical Industries Limited ships Melphalan to 2 countries through 4 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Melphalan Exports?
SUN Pharmaceutical Industries Limited's average Melphalan shipment value is $46.5K per consignment, based on 22 shipments totaling $1.0M. The largest destination is BELGIUM (79.6% of SUN Pharmaceutical Industries Limited's Melphalan exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Melphalan Exporters?
SUN Pharmaceutical Industries Limited ranks #2 among 153 Indian Melphalan exporters with a 8.0% market share. The top 3 exporters are EMCURE PHARMACEUTICALS LIMITED ($8.8M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.0M), EMCURE PHARMACEUTICALS LTD ($443.8K). SUN Pharmaceutical Industries Limited processed 22 shipments to 2 destination countries.
What Melphalan Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MELPHALAN SUN INJECTION 50MG MELPHALANHYDROCHLORIDE 50MG POWDER FOR SOLUTION FOR INFUSION [PACK: 1 VIAL] | $109.2K | 3 |
| MELPHALAN SUN INJ 50MG 1'S VL DE PACK :1 VIAL (BATCH DETAILS AS PER INVOICE)NOS | $100.0K | 2 |
| TARO-MELPHALAN HCL FOR INJECTION 50MG/VIAL (1250 PACK X 1 VIAL) (BATCH NO. HAF2726D MFG DT. 12/2024 EXP DT. 11/2026) | $100.0K | 2 |
| MELPHALAN SUN INJ 50MG 1'S VL GB, PACK :1 Vial, Batch : HAF2726F MFD : 19.12.2024 EXP : 30.11.2026 | $50.0K | 1 |
| TARO-MELPHALAN HCL FOR INJECTION 50 MG/VIAL [2320 PACK X 1 VIAL] | $50.0K | 1 |
| MELPHALAN SUN INJ 50MG 1'S VL IT PACK :1 VIAL (BATCH DETAILS AS PER INVOICE)NOS | $45.7K | 1 |
| MELPHALAN SUN INJECTION 50MG MELPHALANHYDROCHLORIDE 50MG POWDER FOR SOLUTION FOR INFUSION [421 PACK X 1 VIAL] | $41.9K | 1 |
| MELPHALAN SUN INJ 50MG 1'S VL NL PACK :1 VIAL (BATCH DETAILS AS PER INVOICE)NOS | $39.4K | 2 |
| MELPHALAN SUN INJ 50MG 1'S VL FR PACK :1 VIAL (BATCH DETAILS AS PER INVOICE)NOS | $34.6K | 1 |
| MELPHALAN SUN INJ 50MG 1'S VL AT PACK :1 VIAL (BATCH DETAILS AS PER INVOICE)NOS | $31.9K | 1 |
SUN Pharmaceutical Industries Limited exports 17 distinct Melphalan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MELPHALAN SUN INJECTION 50MG MELPHALANHYDROCHLORIDE 50MG POW with 3 shipments worth $109.2K.
Regulatory Requirements: Exporting Melphalan to Key Markets
What SUN Pharmaceutical Industries Limited must comply with to export Melphalan to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Melphalan Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EMCURE PHARMACEUTICALS LIMITED | $8.8M | 221 | 18 | $40.0K |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $1.0M | 22 | 2 | $46.5K |
| 4 | EMCURE PHARMACEUTICALS LTD | $443.8K | 15 | 6 | $29.6K |
| 6 | SP ACCURE LABS PRIVATE LIMITED | $155.0K | 30 | 8 | $5.2K |
SUN Pharmaceutical Industries Limited ranks #2 among 153 Indian Melphalan exporters. Average shipment value of $46.5K compared to the market average of $72.8K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and EMCURE PHARMACEUTICALS LTD.
Which Indian Ports Ship Melphalan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 238 | 28.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 199 | 23.7% |
| Bombay Air | 52 | 6.2% |
| DELHI AIR | 49 | 5.8% |
| DELHI AIR CARGO ACC (INDEL4) | 36 | 4.3% |
| HYDERABAD ACC (INHYD4) | 35 | 4.2% |
| HYDERABAD AIR | 34 | 4.1% |
| Bombay Air Cargo | 25 | 3.0% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Melphalan Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Melphalan, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Melphalan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Melphalan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 22 individual customs records matching SUN Pharmaceutical Industries Limited exporting Melphalan, covering 17 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 97+ countries, 272+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Melphalan Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Melphalan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Melphalan Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Melphalan. For current shipment-level data, contact TransData Nexus.